Abstract
Co-crystals are multicomponent molecular materials held together through non-covalent interactions that have recently attracted the attention of supramolecular scientists. They are the monophasic homogeneous materials where a naturally occurring pharmaceutical active ingredient (API) and a pharmaceutically acceptable co-crystal former are bonded together in a 1:1 via non-covalent forces such as H-bonds, π–π, and van der Waals forces. Co-crystallization is a promising research field, especially for the pharmaceutical industry, due to the enormous potential of improved solubility and bioavailability. Co-crystals are not the only multicomponent molecular materials, as there are many other forms of multicomponent molecular solids such as salts, hydrates, solvates, and eutectics. The formation of co-crystals can roughly be predicted by the value of ∆pKa, that is, if the ∆pKa is more than 3, then this monophasic homogeneous material usually falls in the category of salts, whereas if the ∆pKa is less than 2, then co-crystals are usually observed. A number of methods are available for the co-crystal formation, broadly classified into two classes established on state of formation, that is, solution-based and solid-based co-crystal formation. Similarly, a number of techniques are available for the characterization of co-crystals such as Fourier transforms-infrared spectroscopy, single-crystal and powder X-ray diffraction, etc. In this chapter, we will discuss the available methods for co-crystallization and its characterization.
Keywords
- co-crystallization
- non-covalent interactions
- co-crystallization techniques
- SC-XRD
- FT-IR
1. Introduction
Co-crystals are crystalline complexes containing neutral molecular components combined by non-covalent forces forming a crystal framework [1]. Co-crystals are also defined as the combination of ionic or molecular pharmaceutical active ingredient (API) and co-crystal former that are solid at room temperature [2]. A comparison can also be drawn about the selection of salt. In this instance, the pKa controversy concerns the selection the acid-base duos that combine to form salts. Study displays that a pKa variance of minimum two digits (in base and acid) is essential to generate a salt that is solid in H2O. The formation of co-crystals can roughly be predicted by the value of ∆pKa; that is, if the ∆pKa is more than 3, then this monophasic homogeneous material usually falls in the category of salts, whereas if the ∆pKa is less than 2, then co-crystals are usually observed [3]. Accordingly, solvates hydrates, clathrates, or inclusion compounds (host and guest molecules), and pseudopolymorphs are excluded from the definition of co-crystals because all the mentioned species contain a liquid or gas component under ambient conditions, whereas a co-crystal contains only the solid constituents at room temperature. A general representation of various solid-state systems is given in Figure 1 [1].
Synthesis of co-crystals is a formidable task due to numerous constrictions like the nature of a solvent, the reactants, (1:1) equivalent of the co-crystal former and API, stirring, pH, heat, sort of glassware, etc., which are the effective variables associated with the mechanism of co-crystallization. The question here is how the neutral molecules interact to form a single state of same union (co-crystal) rather than a collection of untainted crystals [4]. The answer to this question is that the force responsible for co-crystal formation is electrostatic in nature; that is, it involves the attraction affinity of negative charge for positive charge. Intermolecular forces like X⋅⋅⋅X interactions (X = F, Cl, Br, I), hydrogen bonding, π⋅⋅⋅π stacking, and van der Waal interactions are involved for the development of co-crystals [5]. Thus, non-covalent interactions are the key factor in designing of co-crystal systems.
Many methods are available for the co-crystal production in which grinding is the pioneer one that was used the first time in 1893 when equal molarities of p-benzoquinone and hydroquinone produced quinhydrone co-crystals [6]. In the interim, numerous new well-defined co-crystals have been formed by both wet grinding and neat methods.
In this chapter, co-crystallization techniques and co-crystallization characterization techniques such as SC-XRD and powder X-ray diffractometry (P-XRD) which are two techniques extensively used for the structure determination of solids having single large crystal and solid in the powder form, respectively, density functional theory (DFT), spectroscopic analysis (UV/IR/FTIR), and morphological (PXRD, SEM, SXRD) and thermal analysis (DSC, TGA) are reviewed.
2. Techniques of co-crystallization
Various methods for co-crystal formation are currently employed, which may be broadly categorized into two classes established on the state of formation: solution-based and solid-based methods [7]. The solution-based techniques utilize large amounts of solvents, which require the separation of solvents after crystallization; on the other hand, solid-based route requires no or limited amount of a solvent [8]. The solution co-crystallization has several advantages over solid-state processes comprising better regulation of crystal properties, higher purity, and greater industrial scale. Solution co-crystallization can completely remove impurities from the crystallized product, helping to restrain challenges to achieve selective polymorphic crystallization. It is also a useful strategy for manufacturing co-crystals on an industrial level as the tools essential for extensive fabrication have been previously widely used in the pharmaceutical, food, and agrochemical manufacturing units. Solution co-crystallization has potential applications in various steps of co-crystal production, from initial screening to scale-up for commercial fabrication [9]. Though the solution co-crystallization is beneficial, solid-state co-crystallization is important from the green chemistry perspective.
2.1 Solution-based co-crystallization of nutraceuticals
Nutraceuticals which are a novel category of mixtures with recognized best-ever protection that can be used as attainable contenders are naturally arising for crystallization in the pharmaceutical industry. In 1989, Nutraceuticals, a terminology devised by DeFelice could be demarcated as a diet (or portion of a diet) that offers health or medical assistance, containing the preclusion or cure of a syndrome. Common types of nutraceuticals comprise polyphenols (e.g., phenolic acids, coumarins, stilbenes, and flavonoids) and vitamins [10]. There exist well-recognized approaches for the preparation of co-crystals, which result in crystals with desirable properties that help to evaluate crystal habit and other characteristics [11]. Isothermal ternary phase diagrams (Figure 2) show co-crystallization stability area when different components of the co-crystal are dissolved in solvents having similar and dissimilar solubility [12].
2.1.1 Evaporative co-crystallization
Co-crystallization is an ordinary evaporation technique for spawning co-crystals, archetypally implemented for procurement of single-crystal co-crystals appropriate for diffraction studies to explicate the co-crystal structure. The procedure embroils the cloud seeding and development of a co-crystal from a solution of equally API and co-crystal former in a solvent, with super-saturation as long as by elimination of the solvent from the solution through vaporization. Distinct co-crystals, or the main part of the crystal sample, are garnered prior the solution vanish to aridness to certify the retrieval of an unsoiled crystal(s). A low degree of desiccation is customarily sought to make sure the development of a large number of minor crystals is disproportionate to an insignificant number of larger crystals. As crystal structure identification is a necessary step in the discovery of novel co-crystal forms, evaporative co-crystallization is evident in the majority of the co-crystal related research papers, and there are countless examples of it in the literature [13].
2.1.2 Cooling co-crystallization
It is performed by decreasing the temperature of the solution. A mixture of components and a solvent is heated to obtain a clear saturated solution and then, the temperature is decreased to get a supersaturated solution, and finally, co-crystals are precipitated out [14]. Cooling of crystals technique was used to formulate co-crystals of nicotinamide:carbamazepine using ethyl alcohol in an excess to create an accessible solution co-crystallization approach. Solvent miscellany, desupersaturation kinetics, and requirement of the thermodynamically stable co-crystal functioning series were used in the design of the procedure, which was displayed throughout to have at 1 L gauge the 90% yield. An analogous methodology was used by Holaň et al. in the formation of citric acid:agomelatine co-crystals, and the effect of freezing level and seed quantity on the crystal proportion dissemination in the concluding yield was evaluated [15].
2.1.3 Reaction co-crystallization
This method is based on the above Figure 2 for components having different solubility in a solvent. A component C1 is added to the solution of a component C2 near its saturation to obtain co-crystals [16]. The reaction co-crystallization is used to harvest co-crystals of carbamazepine:saccharin by mixing different starting solutions of both of the preparatory components. The technique was systematized by the ternary stage illustration and demonstrated a resilient functioning series for the co-crystal development and validated the predictable connection in induction period and supersaturation. Nicotinamide:carbamazepine co-crystal production was also implemented by the reaction co-crystallization using open-air conditions [17].
2.1.4 Isothermal slurry conversion
In this methodology, slurry is obtained with the conversion time depending on various factors such as nucleation, growth kinetics, relative concentration of co-former and API, and the resultant solubility [18]. This methodology implicates the formation of the mixture of the API and co-crystal former, generally in a stoichiometric ratio, in a solvent with a compact portion of deposit incessantly enduring in excess of a solvent. Technique, the addition of the API to a mixture of co-crystal former in a solvent, can be also adjusted in functional terms. However, this is a solution-based process, which does not entail the production of an immaculate (completely dissolved) preliminary solution, as is the situation of prior approaches pronounced above. The degree at which the slurry transformation transpires will diverge centered on the solubility, driving force, the comparative amount of the API and co-crystal former, and the cloud seeding and evolutionary kinetics of the system. A kinetic description of the isothermal slurry transformation of arbitrary co-crystals is inadequate. Zhang et al. scrutinized the adaptation time for theophylline to transform into a stoichiometric ratio glutaric acid co-crystal. While the slurry transformation process usually required a more quantity of starting components and will experience some material damage owing to enduring solubility in the solvent, it is considered as one of the best auspicious screening methodologies owing to its extraordinary proficiency [19].
2.2 Solid state co-crystallization
These methods of co-crystallization involve limited or no use of solvent and are therefore regarded as environment friendly, green, and economically viable. Following procedures are adopted in these methods.
2.2.1 Grinding
Grinding may be either neat grinding, that is, dry grinding or solvent-assisted grinding [20]. In dry or neat grinding method, stoichiometric amounts of selected solids for co-crystallization are mechanically (using mechanical force to create supramolecular synthons, that is, involving mechanochemistry, which is considered as eco-friendly route as it avoids the use of solvents) or manually mixed at high pressure while avoiding their melting [21]. A major disadvantage of the dry grinding is the absence of heating stage involved in co-crystallization, which is shown by many studies to be important in the co-crystallization process [22]. On the other hand in the liquid-assisted milling the above shortcoming is overtaken through adding little amount of liquid to the solids for the co-crystallization. The little quantity of solvent performs as a catalyst for the co-crystal development; better results have been obtained through this method [23]. Two carboxylic acid:sulfathiazole co-crystals were formed by milling stoichiometric proportions of sulfathiazole and the needed carboxylic acid in a Retsch blender grind at a frequency of 25 Hz and a temperature not exceeding 37°C for 90 min and it was done [22]. Compared with solution-based approaches, solid milling is associated with higher performance because no product is lost due to its solubility in a solvent. Problems with dry milling can comprise impossibility to form a co-crystal, inadequate modifications to the co-crystal, and crystalline flaws with the presence of possible several amorphous compounds [24].
2.2.2 Contact formation
Co-crystals have been prepared through mixing without using any mechanical force; however, this process requires controlled conditions of temperature and pressure. Various factors affect the formation of co-crystals such as pre-milling, moisture, and size of premixed materials [25, 26]. The extemporaneous production of co-crystals by intermixing an uncontaminated target molecule and co-crystal former using organized conditions has been stated. During co-crystallization, no mechanical forces are employed in this technique. However, in various circumstances, slight milling of untainted constituents separately afore intermixing has been completed. The impact on the co-crystallization rate of pre-milling of the elementary constituents carbamazepine and nicotinamide was described by Rodriguez-Hornedo et al. It was shown that the co-crystallization rate can be increased by using milled components as compared to unmilled components (12 vs. 80 days, correspondingly). Furthermore, the greater co-crystallization degree has been described for the indistinguishable arrangement at maximum temperatures and comparative dampness, nevertheless of the mechanical stimulation [20]. The formation of an isoniazid benzoic acid co-crystal
2.2.3 Twin screw extrusion
In twin screw extrusion (TSE) technique, the mixing of materials is carried out in a device known as a twin screw extruder in which milling of the starting materials is carried out below their melting points. Proficient intermixing and high surface interaction and consequently enhanced co-crystal formation are achieved without using the solvent provided by this method [25, 26]. The two co-/counter-rotating screws are accompanied by twin screw units in a solitary barrel. Screw activity offers immediate intermixing and mobility of components sideways the span of the barrel. The materialization of four model co-crystals consumes a 16 mm TSE with four manageable temperature regions as reported by Daurio et al. Theophylline:citric acid, carbamazepine:saccharin, nicotinamide:cinnamic acid, and caffeine:oxalic acid co-crystals were formed by slight grinds of the dry fine particles of both starting components
2.2.4 Hot melt extrusion (HME)
Hot melt extrusion is a comparatively modern addition to the co-crystal grounding options. Using a warmed screw extruder, this special technique achieves simultaneous softening and combining of the API and co-crystal former. Usually, the initial components are combined in the definite stoichiometric ratio and supplied to the warmed extruder. The complete intermixing of the starting components in the stoichiometric ratio occurs by melting. The co-crystal nucleates amenably in the melt and the uncontaminated co-crystal extrudate is separated from the extruder constantly. The benefits of the technique are as follows: the purging using organic solvents, rapid working times, improved adaptation compared with the solution-based techniques, reduced leftover, and the tools offering itself well to the constant drug manufacturing [8].
This method helps in avoiding solvents and saves time due to the increased conversion to co-crystals. Besides other benefits of HME, this method falls within the requirement of US FDA practice analytical expertise for controlling, analyzing, and designing the engineering of pharmaceuticals. For example, drugs such as Rezulin, Kaletra, and Norvir have been prepared through this method and got FDA approval [28]. Other benefits include scaling-up of production to an industrial scale and being more economical because it is a continuous process.
2.3 Miscellaneous methods of co-crystal preparation
2.3.1 Heat-induced co-crystallization
Co-crystallization method using heat is a novel method to form co-crystals. It has several advantages compared with the solvent evaporation method such as it does not need any organic solvent and can be used without drug coformer solubility determination that is a time-consuming and laborious work [29].
2.3.2 Spray drying method
Spray drying is an instant and incessant method for solid manufacturing, generating dry fine particles from precursor
2.3.3 Supercritical fluid technology
Materials that have pressure and temperature greater than their critical state (Pc and Tc) are supercritical fluids. The leading objective of supercritical fluid technology is to regulate cloud seeding and crystal development courses. The most conspicuous supercritical fluid used in the pharmaceutical arena is carbon dioxide, with critical temperature and pressure of 31.0°C and 7.39 atm, respectively, because of its non-toxicity, non-flammability, and low-cost properties [22, 33]. Numerous approaches of employing the supercritical fluid carbon dioxide to produce co-crystals are as follows: (1) where CO2 is used as an anti-solvent known as gas anti-solvent crystallization (GAS). As an example, the SAS (supercritical anti-solvent crystallization) and AAS (atomization and anti-solvent crystallization) methods of supercritical fluid technology were successfully used in the formation of the indomethacin:saccharin co-crystal, (2) where the carbon dioxide is used as a liquid and molecular movement enhancer called co-crystallization with the supercritical solvent (CSS), (3) where CO2 is utilized as a solvent and molecular movement enhancer called supercritical anti-solvent crystallization (SAS), (4) where CO2 is used as corsage enhancer or anti-solvent called atomization and anti-solvent crystallization (AAS), (5) where CO2 is used as corsage enhancer or anti-solvent called supercritical fluid improved atomization (SEA), and (6) where CO2 is used as a solvent known as rapid expansion of supercritical solutions (RESS) [34].
2.3.4 Laser irradiation
A current technique for co-crystallization described by Titapiwatanakun et al. uses carbon dioxide irradiation treatment for the production of a malonic acid:caffeine (1:2) and oxalic acid:caffeine (1:2) co-crystals. The energy given to the unit throughout irradiation spawns a quick escalation in heat in a short period, triggering the softening of the crystalline compound, monitored by material intermixing, and next prompts recrystallization upon freezing. In this scheme, requirements for a co-crystal former component that can be used for this process are that a co-crystal former is necessarily sublimable, to accelerate a cloud seeding method by the vapor phase [35].
2.3.5 Electrochemically induced co-crystallization
Urbanus et al. reported the perspective of using co-crystallization in combination with electrochemistry to exclude
2.3.6 Acoustic resonant mixing
Acoustic resonant mixing (RAM) is used to combine the API and co-crystal former in the existence of a solvent to produce a co-crystal without any milling media. The supply of mechanical energy into a wet powder mixture is performed acoustically, promoting the complete intermixing of the constituents. Utilizing a laboratory RAM resonant acoustic blender operating at 80−100G and 60 Hz, a series of carbamazepine co-crystals have been efficaciously formed. The co-crystal product has been separated at a wide array of gauges from the lab, 100 mg, 1.5 g, and 22 g, and the equipment seems to hold itself up to scale [37].
2.3.7 Freeze-drying
Freeze drying, in principle recognized as lyophilization, has primarily been employed as dispensing scheme for a range of products, including foodstuff and drugs. The procedure functions to sublimate the component directly from the solid phase to the gas phase by decreasing the ambient pressure to cause the freezing of H2O within the component also known as sublimation. It has also recently emerged as a viable process for preparing novel solid-state forms of co-crystals. Eddleston et al. reported the preparation of new theophylline:oxalic acid co-crystals by lyophilization. Co-crystallization occurs through an amorphous state that is produced as solvent sublimes throughout lyophilization [38].
2.3.8 Electrospray technology
Electrospray is a method that uses an electric field to create and charge droplets at the same time. In this method, the solutes (substances to be dissolved) are carried by a solution that flows out of a capillary nozzle at a high potential and is subjected to an electric field, which causes the droplets of solution to elongate and create a jet. After the solution jet has been dried, the resulting particles can be collected using a powder collector that has already been loaded with material. Co-crystals of carbamazepine and itraconazole with a variety of coformers were reported as a possible outcome of this procedure by Patil et al. [39].
2.4 Nano co-crystallization
Pharmaceutical nano co-crystals can considerably enhance the delivery qualities of ailing decipherable medicines, which have long posed a considerable issue for the pharmaceutical business. The investigation is into the production of nano co-crystals with high commercial value. Methods such as precipitation, media grinding, and high-pressure homogenization can be used to manufacture nanocrystals on a large scale. When delivered orally, intravenously, pulmonaryly, ocularly, or topically, nanocrystals exhibited the promising therapeutic utility. In addition, nanostructured medicinal molecules can be targeted to specific locations. Usually formation process for the nano-crystals comprising top-down flow process is a ball grinding technique that uses shear forces to produce high-pressure homogeneous nano-size particles. Precipitation is one of the bottom-up procedures that includes the growth [40].
3. Co-crystal characterization
The determination of physicochemical properties of co-crystals is an important part of the research, and therefore, the combination of techniques is employed for the co-crystal characterization, as no single method can fully elucidate their structure and properties [41]. The following characterization techniques for the structure determination are outlined and represented diagrammatically in Figure 3 [30].
3.1 Analyzing structure through XRD
Powder-XRD and SC-XRD are two techniques extensively used for the structure determination of solids having single large crystal and solid in the powder form, respectively. The SC-XRD elucidates the structural properties such as lattice parameters, unit cell, space group, and intermolecular interactions and is the most reliable technique [31]. However, the drawback of the method is that obtaining single crystals is a difficult task and PXRD cannot differentiate between co-crystal and additional solid states such as polymorph, solvate, and hydrate [33].
3.2 Thermal analysis
Differential scanning calorimetry (DSC) is a frequently used technique for gaining thermal information such as enthalpy of melting and other melting data and is used for screening of co-crystals [22]. The type of solid formed can be identified from DSC thermogram. For example, a physical mixture has two endotherms indicating the melting points of components with no intermolecular forces between them [42], and a eutectic system has a particular endotherm having latent heat, not more than the corresponding components [43], while a co-crystal has a particular endotherm having latent heat lesser, higher, or in the middle of the parent components [44].
3.3 Spectroscopic methods
Various spectroscopic techniques such as Raman, nuclear magnetic reso¬nance (NMR), Fourier transform (FT-IR) infra-red spectroscopies, terahertz (THz) spectroscopic imaging, and various advanced applications of these methods are in practice to investigate the structure of co-crystals and find out the intermolecular forces between the components of co-crystals [45, 46].
4. Conclusions
Co-crystallization is an effective tool and suggests one of the best auspicious routes to modify the physicochemical characteristics of the merging components. There are several methods for preparing co-crystals, extending from ordinary lab-size production to possibly large-scale unremitting fabrication. In this chapter, we have described the established and emerging approaches to co-crystal prepara-tion. Moreover, insights into the mechanisms of formation and techniques of characterization of co-crystals have also been presented.
References
- 1.
Schulthesisx N, Newman A. Pharmaceutical co-crystals and their physicochemical properties. Crystal Growth & Design. 2009; 9 (6):2950-2967 - 2.
Vishweshwar P, McMahon JA, Bis JA, Zaworotko MJ. Pharmaceutical co-crystals. Journal of Pharmaceutical Sciences. 2006; 95 (3):499-516 - 3.
Yadav AV, Shete AS, Dabke AP, Kulkarni PV, Sakhare SS. Co-crystals: A novel approach to modify physicochemical properties of active pharmaceutical ingredients. Indian Journal of Pharmaceutical Sciences. 2009; 71 (4):359 - 4.
Maruyoshi K, Iuga D, Antzutkin ON, Alhalaweh A, Velaga SP, Brown SP. Identifying the intermolecular hydrogen-bonding supramolecular synthons in an indomethacin–nicotinamide cocrystal by solid-state NMR. Chemical Communications. 2012; 48 (88):10844-10846 - 5.
Gao Y, Gao J, Liu Z, Kan H, Zu H, Sun W, et al. Coformer selection based on degradation pathway of drugs: A case study of adefovir dipivoxil–saccharin and adefovir dipivoxil–nicotinamide cocrystals. International Journal of Pharmaceutics. 2012; 438 (1-2):327-335 - 6.
Zhu W, Dong H, Zhen Y, Hu W. Challenges of organic “cocrystals”. Science China Materials. 2015; 58 (11):854-859 - 7.
He G, Jacob C, Guo L, Chow PS, Tan RB. Screening for co-crystallization tendency: The role of intermolecular interactions. The Journal of Physical Chemistry. B. 2008; 112 (32):9890-9895 - 8.
Karimi-Jafari M, Padrela L, Walker GM, Croker DM. Creating cocrystals: A review of pharmaceutical cocrystal preparation routes and applications. Crystal Growth & Design. 2018; 18 (10):6370-6387 - 9.
Sopyan I, Fudholi A, Muchtaridi M, Sari P. Co-crystallization: A tool to enhance solubility and dissolution rate of simvastatin. Journal of Young Pharmacists. 2017, 1; 9 (2) - 10.
Sinha AS, Maguire AR, Lawrence SE. Cocrystallization of nutraceuticals. Crystal Growth & Design. 2015; 15 (2):984-1009 - 11.
Trask AV, Jones W. Crystal engineering of organic cocrystals by the solid-state grinding approach. In: Organic Solid-State Reactions. Berlin, Heidelberg: Springer; 2005. pp. 41-70 - 12.
Ainouz A, Authelin JR, Billot P, Lieberman H. Modeling and prediction of co-crystal phase diagrams. International Journal of Pharmaceutics. 2009; 374 (1-2):82-89 - 13.
Wang IC, Lee MJ, Sim SJ, Kim WS, Chun NH, Choi GL. Anti-solvent co-crystallization of carbamazepine and saccharin. International Journal of Pharmaceutics. 2013; 450 (1-2):311-322 - 14.
McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, et al. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharmaceutical Research. 2006; 23 (8):1888-1897 - 15.
Gröls JR, Castro-Dominguez B. Mechanochemical co-crystallization: Insights and predictions. Computers & Chemical Engineering. 2021; 153 :107416 - 16.
Childs SL, Rodríguez-Hornedo N, Reddy LS, Jayasankar A, Maheshwari C, McCausland L, et al. Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine. CrystEngComm. 2008; 10 (7):856-864 - 17.
Zata Lini F, Pratama DE, Lee T. Co-crystallization kinetics of 2:1 benzoic acid–sodium benzoate Co-crystal: The effect of templating molecules in a solution. Crystals. 2021; 11 (7):812 - 18.
Jayasankar A, Reddy LS, Bethune SJ, Rodríguez-Hornedo N. Role of cocrystal and solution chemistry on the formation and stability of cocrystals with different stoichiometry. Crystal Growth & Design. 2009; 9 (2):889-897 - 19.
Jia Q , Wang J, Zhang S, Zhang J, Liu N, Kou K. Investigation of the solid–liquid ternary phase diagrams of 2HNIW• HMX cocrystal. RSC Advances. 2021; 11 (16):9542-9549 - 20.
Braga D, Giaffreda SL, Grepioni F, Pettersen A, Maini L, Curzi M, et al. Mechanochemical preparation of molecular and supramolecular organometallic materials and coordination networks. Dalton Transactions. 2006; 10 :1249-1263 - 21.
Friscic T, Jones W. Recent advances in understanding the mechanism of co-crystal formation via grinding. Crystal Growth & Design. 2009; 9 (3):1621-1637 - 22.
Mohammad AA, Velaga S. International Journal of Pharmaceutics. 2011; 407 :63-71 - 23.
Padrela L, de Azevedo EG, Velaga SP. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture. Drug Development and Industrial Pharmacy. 2012; 38 (8):923-929 - 24.
Chaudhari KR, Savjani JK, Savjani KT, Shah H. Improved pharmaceutical properties of ritonavir through co-crystallization approach with liquid-assisted grinding method. Drug Development and Industrial Pharmacy. 2022; 23 :1-0 - 25.
Ervasti T, Ketolainen J, Altonen JA. Spontaneous formation of theophylline–nicotinamide co-crystals. Scientia Pharmaceutica. 2010; 78 (3):622 - 26.
Nartowski KP, Khimyak YZ, Berry DJ. Tuning the spontaneous formation kinetics of caffeine: Malonic acid co-crystals. CrystEngComm. 2016; 18 (15):2617-2620 - 27.
Bairagi KM, Ingle KS, Bhowal R, Mohurle SA, Hasija A, Alwassil OI, et al. Interplay of halogen and hydrogen bonding through co–crystallization in pharmacologically active dihydropyrimidines: Insights from crystal structure and energy framework. ChemPlusChem. 2021; 86 (8):1167-1176 - 28.
Shan N, Toda F, Jones W. Mechanochemistry and co-crystal formation: Effect of solvent on reaction kinetics. Chemical Communications. 2002; 20 :2372-2373 - 29.
Kshirsagar SM, Chatale BC, Amin PD. Comparative evaluation of ibuprofen co-crystals prepared by solvent evaporation and hot melt extrusion technology. Journal of Drug Delivery Science and Technology. 2022; 1 (67):103003 - 30.
Healy AM, Worku ZA, Kumar D, Madi AM. Pharmaceutical solvates, hydrates and amorphous forms: A special emphasis on cocrystals. Advanced Drug Delivery Reviews. 2017; 117 :25-46 - 31.
Sathisaran I, Dalvi SV. Engineering cocrystals of poorly water-soluble drugs to enhance dissolution in aqueous medium. Pharmaceutics. 2018; 10 (3):108 - 32.
Tzatsi P, Goula AM. Encapsulation of extract from unused chokeberries by spray drying, co-crystallization, and ionic gelation. Waste and Biomass Valorization. 2021 Aug; 12 (8):4567-4585 - 33.
Miroshnyk I, Mirza S, Sandler N. Pharmaceutical co-crystals–An opportunity for drug product enhancement. Expert Opinion on Drug Delivery. 2009; 6 (4):333-341 - 34.
Obaidat R, Al-Ghzawi B, Al-Taani B, Al-Shari N. Co-crystallization of amoxicillin trihydrate and potassium clavulanate provides a promising approach for preparation of sustained-release microspheres. AAPS PharmSciTech. 2022; 23 (5):1-4 - 35.
Tsuchida S, Umemura H, Murata S, Miyabe A, Satoh M, Matsushita K, et al. Effect of humidity during sample preparation on bacterial identification using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Journal of Chromatography B. 2021; 30 (1176):122780 - 36.
Wang Z, Li R, Zhao K, Yu F, Zhao J, Zhen Y, et al. A co-crystallization strategy toward high-performance n-type organic semiconductors through charge transport switching from p-type planar azaacene derivatives. Journal of Materials Chemistry C. 2022; 10 (7):2757-2762 - 37.
Ngilirabanga JB, Samsodien H. Pharmaceutical co-crystals: An alternative strategy for enhanced physicochemical properties and drug synergy. Nano Select. 2021; 2 (3):512-526 - 38.
Si-yu LI, Chen-guang ZH, Ming-xing ZH. Hot aerosol extinguishing agent based on freeze-drying co-crystallization process. Fire Science and Technology. 2021, 15; 40 (1):64 - 39.
Ngilirabanga JB, Samsodien H. Pharmaceutical co-crystal: An alternative strategy for enhanced physicochemical properties and drug synergy. Nano Select. 2021; 2 (3):512-526 - 40.
Peltonen L. Practical guidelines for the characterization and quality control of pure drug nanoparticles and nano-cocrystals in the pharmaceutical industry. Advanced Drug Delivery Reviews. 2018; 131 :101-115. DOI: 10.1016/j.addr.2018.06.009 - 41.
Li N, Qiao MW, Schlindwein N, Malek AD, Trappitt G. Pharmaceutical co-crystals: An overview. International Journal of Pharmaceutics. 2011; 419 (1-2):1-11 - 42.
Cherukuvada S, Nangia A. Eutectics as improved pharmaceutical materials: Design, properties and characterization. Chemical Communications. 2014; 50 (8):906-923 - 43.
Yamashita H, Hirakura Y, Yuda M, Terada K. Coformer screening using thermal analysis based on binary phase diagrams. Pharmaceutical Research. 2014; 31 (8):1946-1957 - 44.
Schultheiss N, Newman A. Pharmaceutical cocrystals and their physicochemical properties. Crystal Growth & Design. 2009; 9 (6):2950-2967 - 45.
Chi Z, Wang M, Yang L, Li X, Cong X, Liu S, et al. Fourier transform near-infrared spectroscopy used for purity determination of rhein-L-arginine cocrystal (argirein). Analytical Sciences. 2013; 29 (6):661-664 - 46.
Vogt FG, Clawson JS, Strohmeier M, Edwards AJ, Pham TN, Watson SA. Solid-state NMR analysis of organic cocrystals and complexes. Crystal Growth & Design. 2009; 9 (2):921-937 - 47.
Rodríguez-Hornedo N, Nehm SJ, Seefeldt KF, Pagan-Torres Y, Falkiewicz CJ. Reaction crystallization of pharmaceutical molecular complexes. Molecular Pharmaceutics. 2006; 3 (3):362-367